Wednesday, March 19, 2025
Home Authors Posts by Editor / Curator

Editor / Curator

932 POSTS 0 COMMENTS
All News

‘Early Detection, Early Response.’ How Smallpox Which Killed 300 Million, Was...

Editor / Curator -
Biotech Stock Review
Superbug News - CoronaVirus Watch List

Regular Old Flu, Kills 290,000 to 650,000 a Year.

Editor / Curator -
Superbug News - CoronaVirus Watch List

Let’s be ‘Corona Clever’ and Catch one Before the POP. Athersys...

Editor / Curator -
video
Superbug News - CoronaVirus Watch List

CoronaVirus Story of the Day. “How Lucky Can One Guy Be.”

Editor / Curator -
Superbug News - CoronaVirus Watch List

Todos Medical (TOMDF) Issues Another CoronaVirus Headline, Gains 60%.

Editor / Curator -
Aphex BioCleanse
Superbug News - CoronaVirus Watch List

Aphex BioCleanse Systems. Our Favorite CoronaVirus Story.

Editor / Curator -
Stand Down.

Stand Down VII: Could We Have a Down 20% Day?

Editor / Curator -
Superbug News - CoronaVirus Watch List

Telehealth DTC Startup Ro is now Offering Coronavirus Assessments (ModernRetail).

Editor / Curator -
coronavirus stocks
Superbug News - CoronaVirus Watch List

Coronavirus Stock Mania. 800% Gain, Seen in a Single Day on...

Editor / Curator -
Biotech Stock Review
Superbug News - CoronaVirus Watch List

Coronavirus Stocks Still on a Tear.

Editor / Curator -
1...707172...94Page 71 of 94

Latest article

Zomedica (ZOMDF) Surges 40% Higher, Friday.

Uncategorized Editor / Curator -
Stock Surges 40%, After Management Conference Call to Calm the Natives. Insider Buying Unleashed Today? Not...

And We Have a Trading Idea!

2025 Watch List Editor / Curator -
Adding Zomedica (ZOM, ZOMDF) $0.037 to Watch List. Our first 'publicly announced' trading idea, in what might be decades....

We’re Back! And We’re Adding (again), GeoVax (GOVX), the Alkaline Water Co (WTER) and...

2025 Watch List Editor / Curator -
GeoVax (GOVX) $1.64. Recent High $11.18 (BiotechStockReview) The Alkaline Water Co. (WTER) $0.09. Recent High $0.48 (BeverageStockReview)
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.